Stay updated with breaking news from Human Use. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Colin Kellaher Merck & Co. on Friday said the European Medicines Agency's Committee for Medicinal Products for Human Use recommended expanded approval of its blockbuster cancer drug...
The European Medicines Agency granted marketing authorization for tislelizumab and retifanlimab for the treatment of non–small cell lung cancer and Merkel cell carcinoma, respectively.
The vaccines, Celldemic and Incellipan, protect against the H5N1 subtype of the influenza A virus.
Treatments for amyotrophic lateral sclerosis and paroxysmal nocturnal hemoglobinuria have been given marketing authorization by the European Medicines Agency.
